Profit Collapse Masks a Margin Crisis, Not a Growth Hiccup

The quarter presents a paradox that defines the earnings crisis: revenue grew double-digits, but profit collapsed into a single-digit net margin. This is not a cyclical slowdown or a working-capital hiccup—it is a fundamental breakdown of operating leverage. Raw material costs rose 3% quarter-on-quarter, while cost-reduction initiatives delivered only 2% in Kaizen savings. Pricing power, critically, remains absent. The company installed 23,865 solar pump units—a respectable 7% growth—but was forced to absorb margin pressure rather than pass it through. With KUSUM 2.0 still in government revisions and backward solar integration assets not yet revenue-producing, management has no near-term lever to recover the 6–7 percentage points of margin lost this year.

At a 12% revenue growth rate, the market would normally expect net profit to expand in line or better. Instead, net margin compressed from ~11–12% in prior quarters to 5.1%—a 6–7 point destruction. The culprit is not sales mix; it is raw material inflation combined with zero pricing flexibility.

This quarter marked a visible shift in tone from the prior FY27 Q1 call. Guidance reaffirmed but trajectory worsened: management maintained claims of 15–17% sustainable margins, but delivered a 5.1% net margin—6–7 points below prior levels. KUSUM 2.0 slipped further: the Q1 call implied FY27 clearance; this call acknowledged the scheme is 'undergoing revisions' at the PM level and timing cannot be predicted—a 6+ month slip from prior expectations. Backward solar integration remains unproductive: the 500 MW solar cell facility commenced trial production with expected commercial output in 1.5 months; zero revenue contribution yet, deferring margin recovery catalysts to Q4 FY27 at earliest. Debt trajectory and capex on track: ₹1,700 Cr capex plan for FY27–FY28 maintained at a 50–50 split; debt expected below ₹500 Cr by year-end from October collections of ₹400 Cr.

The market's verdict has been unambiguous and harsh. The stock trades at ₹353.65, down 74.5% from its all-time high of ₹1,387—a multi-year drawdown that reflects institutional recognition of a structurally damaged earnings story. Technical indicators confirm extreme distress: RSI at 18 marks severe oversold territory, and the price sits below its 20-day, 50-day, and 200-day simple moving averages (trading at ₹353.65 vs SMA20 ₹408.68, SMA50 ₹450.66, SMA200 ₹527.47). Volume is increasing, a sign that selling pressure is not yet exhausted.

Institutional flows are highly concerning. FII ownership held steady at 5.08% in Q1 FY-2027, but DII (domestic institutional) holdings collapsed from 6.30% in Q3 FY-2026 to just 2.39% in Q1 FY-2027—a 2.58 percentage-point exit that signals loss of confidence among Indian mutual funds and insurance companies. Promoters remain locked in at 50.36%, offering no visibility into insider sentiment. The DII exit is the canary in the coal mine: sophisticated domestic investors have recognized that the margin recovery thesis is no longer credible.

The gap between the fundamentals and price action is closing. A stock trading 74.5% below ATH with worsening earnings, delayed catalysts, and weak institutional support has little downside cushion—but also little near-term catalyst for recovery. Recovery hinges entirely on execution: backward integration must prove profitable, KUSUM must clear by Q3, and pricing power must emerge. Until that proof arrives, the stock remains a 'show me' story, not a recovery bet.